2024-12-24 01:47:57
Alterity Receives Non-Compliance Notice Regarding NASDAQ Minimum Bid Price Requirement
Corporate/ 2023-07-23
Alterity Receives Non-Compliance Notice ...

MELBOURNE,Australiaand SAN FRANCISCO,Feb. 7,2020-- Alterity Therapeutics Limited(ASX:ATH,NASDAQ:ATHE) has received notification from the Lis...

GSK announces European Medicines Agency (EMA) accepted marketing authorisation application for belantamab mafodotin for the treatment of relapsed or refractory multiple myeloma
Corporate/ 2023-07-23
GSK announces European Medicines Agency ...

- Belantamab mafodotin accepted for accelerated assessment by the EMA\'s Committee for Human Medicinal Products (CHMP)

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release